ClinConnect ClinConnect Logo
Search / Trial NCT06963424

Pain Relief and and Peripheral Perfusion Index During Erector Spinae Block

Launched by KEIMYUNG UNIVERSITY DONGSAN MEDICAL CENTER · May 6, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a procedure called the erector spinae block, which is used to help relieve back pain. Researchers want to find out how effective this method is in reducing pain and improving blood flow in patients by injecting local anesthetics in different areas of the back. They will also look at any pain associated with the procedure itself.

To participate in this study, you may be eligible if you have certain back conditions, such as a herniated disc or spinal stenosis, and if your pain has lasted longer than a month with a moderate to severe pain level. However, you cannot take part if you have allergies to certain medications, are pregnant, have had previous spine surgery, or have certain medical conditions like abnormal bleeding. This study is not recruiting participants yet, so there will be more information available once it begins. If you decide to participate, you can expect to receive support and information throughout the process to help manage your back pain better.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • lumbar disc herniation
  • lumbar foraminal stenosis
  • lumbar central stenosis
  • lumbar spondylolisthesis
  • numerical rating scale \> 4
  • back pain functional scale \< 45
  • duration of pain \> 1 mon
  • patients who can fully understand all items described in back pain functional scale
  • Exclusion Criteria:
  • Allergy to local anesthetics or contrast medium
  • Pregnancy
  • Spine deformity
  • Prior history of lumbar spine surgery
  • No previous lumbar MRI or CT
  • Patients with coagulation abnormality

About Keimyung University Dongsan Medical Center

Keimyung University Dongsan Medical Center is a premier academic medical institution located in Daegu, South Korea, dedicated to advancing healthcare through innovative research and clinical excellence. As a sponsor of clinical trials, the center is committed to conducting high-quality studies that aim to improve patient outcomes and contribute to the global body of medical knowledge. Leveraging its state-of-the-art facilities and a multidisciplinary team of experienced healthcare professionals, Keimyung University Dongsan Medical Center fosters a collaborative environment for researchers and participants, ensuring rigorous adherence to ethical standards and regulatory guidelines throughout the research process.

Locations

Daegu, , Korea, Republic Of

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported